— Know what they know.
/
Not Investment Advice

VERA NASDAQ

Vera Therapeutics, Inc.
1W: -0.2% 1M: -7.7% 3M: -7.8% YTD: -38.3% 1Y: +2.6% 3Y: +204.8% 5Y: +77.2%
$29.99
+1.69 (+5.97%)
After Hours: $30.03 (+0.04, +0.13%)
Weekly Expected Move ±8.1%
$23 $26 $28 $30 $33
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 30 · $2.2B mcap · 59M float · 3.86% daily turnover · Short 44% of daily vol
Credit Risk of going bust: lower than 62% of companies Debt: 3.6% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.13 (down 99.6%), Vera Therapeutics, Inc. would be worth roughly what it owes.
Total debt $75.2M against a stock market value of $2.04B.
Distance to default 6.46 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $37.6M (short-term plus half of long-term), stock volatility 61.0%; Altman Z'' -1.67. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview News Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings
Dividends Analysis Technicals Weather Peers ESG Institutions ETF Exposure Dark Pool Short Interest Supply Chain
#110 of 1060
Biotechnology
Healthcare · Mid Cap · 217 peers
Market Share
0.2%
Top 4 Concentration: 22.6%

Technical Signal Map

85 Bullish
14 Neutral
119 Bearish
VERA $2.0B
Vera Therapeutics, Inc.
BEARISH -49
LZAGY $54B
Lonza Group AG
BULLISH +100
ASND $15B
Ascendis Pharma A/S
BULLISH +100
HALO $14B
Halozyme Therapeutics, Inc.
BULLISH +100
CAI $9.1B
Caris Life Sciences, Inc.
BULLISH +100
MANE $5.8B
Veradermics, Incorporated
BULLISH +100
BVNRY $2.9B
Bavarian Nordic A/S
BULLISH +100
NRIX $2.8B
Nurix Therapeutics, Inc.
BULLISH +100
FTRE $2.2B
Fortrea Holdings Inc.
BULLISH +100
AGIO $2.2B
Agios Pharmaceuticals, Inc.
BULLISH +100
LKFT $2.1B
Lakefront Biotherapeutics N.V.
BULLISH +100
SEPN $1.9B
Septerna Inc
BULLISH +100
COAG $1.6B
Hemab Therapeutics Holdings, Inc. Common Stock
BULLISH +100
VSTM $910M
Verastem, Inc.
BULLISH +100
SOLTF $770M
Nxera Pharma Co., Ltd.
BULLISH +100
REGN $83B
Regeneron Pharmaceuticals, Inc.
BULLISH +91
EXEL $16B
Exelixis, Inc.
BULLISH +91
ARQT $3.9B
Arcutis Biotherapeutics, Inc.
BULLISH +91
VCEL $2.2B
Vericel Corporation
BULLISH +91
MRVI $2.1B
Maravai LifeSciences Holdings, Inc.
BULLISH +91
KLRA $1.7B
Kailera Therapeutics, Inc.
BULLISH +91
SPTX $1.1B
Seaport Therapeutics, Inc. Common Stock
BULLISH +91
SGP $950M
SpyGlass Pharma, Inc. Common Stock
BULLISH +91
VRDN $2.5B
Viridian Therapeutics, Inc.
BULLISH +87
ADMA $2.4B
ADMA Biologics, Inc.
BULLISH +87
UTHR $25B
United Therapeutics Corporation
BULLISH +84
KYMR $9.1B
Kymera Therapeutics, Inc.
BULLISH +84
LEGN $3.6B
Legend Biotech Corporation
BULLISH +84
VIR $1.8B
Vir Biotechnology, Inc.
BULLISH +82
MAZE $1.7B
Maze Therapeutics, Inc.
BULLISH +78
GNMSF $28B
Genmab A/S
BULLISH +75
SYRE $8.3B
Spyre Therapeutics, Inc.
BULLISH +75
TGTX $8.3B
TG Therapeutics, Inc.
BULLISH +75
ORKA $5.3B
Oruka Therapeutics, Inc.
BULLISH +75
IRON $2.9B
Disc Medicine, Inc.
BULLISH +75
BHVN $2.1B
Biohaven Ltd.
BULLISH +75
ZYME $2.0B
Zymeworks Inc.
BULLISH +75
LBRX $1.2B
LB Pharmaceuticals Inc Common Stock
BULLISH +75
OABIW $1.1B
OmniAb, Inc.
BULLISH +75
RIGL $900M
Rigel Pharmaceuticals, Inc.
BULLISH +75
ONTTF $2.7B
Oxford Nanopore Technologies plc
BULLISH +74
NBIX $15B
Neurocrine Biosciences, Inc.
BULLISH +68
ERAS $5.0B
Erasca, Inc.
BULLISH +68
RARE $1.5B
Ultragenyx Pharmaceutical Inc.
BULLISH +68
CSLLY $134B
CSL Limited
BULLISH +66
LGND $6.0B
Ligand Pharmaceuticals Incorporated
BULLISH +66
AUPH $2.2B
Aurinia Pharmaceuticals Inc.
BULLISH +66
XNCR $1.9B
Xencor, Inc.
BULLISH +66
TRAX $1.6B
First Tracks Biotherapeutics Inc
BULLISH +66
SLN $930M
Silence Therapeutics plc
BULLISH +66
NBTX $1.5B
Nanobiotix S.A.
BULLISH +62
SLS $2.3B
SELLAS Life Sciences Group, Inc.
BULLISH +59
NTLA $1.6B
Intellia Therapeutics, Inc.
BULLISH +59
PHAR $710M
Pharming Group N.V.
BULLISH +59
TECH $11B
Bio-Techne Corporation
BULLISH +58
IOVA $6.4B
Iovance Biotherapeutics, Inc.
BULLISH +58
KOD $5.5B
Kodiak Sciences Inc.
BULLISH +58
MRNA $80B
Moderna, Inc.
BULLISH +56
AKBLF $7.4B
ALK-Abelló A/S
BULLISH +53
CASBF $1.4B
CanSino Biologics Inc.
BULLISH +52
REPL $1.1B
Replimune Group, Inc.
BULLISH +52
ROIV $26B
Roivant Sciences Ltd.
BULLISH +50
ABSI $1.6B
Absci Corporation
BULLISH +50
XERS $1.9B
Xeris Biopharma Holdings, Inc.
BULLISH +49
BBIO $13B
BridgeBio Pharma, Inc.
BULLISH +43
VOR $990M
Vor Biopharma Inc.
BULLISH +43
ONC $40B
BeOne Medicines AG
BULLISH +42
RXRX $2.0B
Recursion Pharmaceuticals, Inc.
BULLISH +42
IMCR $1.6B
Immunocore Holdings plc
BULLISH +41
DMRA $1.3B
Damora Therapeutics, Inc.
BULLISH +40
MLTX $1.0B
MoonLake Immunotherapeutics
BULLISH +40
COGT $5.4B
Cogent Biosciences, Inc.
BULLISH +36
ALMR $2.1B
Alamar Biosciences, Inc.
BULLISH +35
VRTX $133B
Vertex Pharmaceuticals Incorporated
BULLISH +34
RLAY $4.0B
Relay Therapeutics, Inc.
BULLISH +34
DYN $2.9B
Dyne Therapeutics, Inc.
BULLISH +33
UCBJY $58B
UCB S.A.
LEAN BULL +28
PTGX $9.0B
Protagonist Therapeutics, Inc.
LEAN BULL +27
DFTX $4.8B
Definium Therapeutics, Inc.
LEAN BULL +27
ELVN $3.0B
Enliven Therapeutics, Inc.
LEAN BULL +18
PHVS $2.2B
Pharvaris N.V.
LEAN BULL +18
STOK $1.6B
Stoke Therapeutics, Inc.
LEAN BULL +18
BRVE $1.5B
Braveheart Bio, Inc.
LEAN BULL +15
PVLA $1.8B
Palvella Therapeutics, Inc.
LEAN BULL +11
TYRA $1.2B
Tyra Biosciences, Inc.
LEAN BULL +11
BEAM $2.5B
Beam Therapeutics Inc.
LEAN BULL +10
SRPT $1.9B
Sarepta Therapeutics, Inc.
NEUTRAL +9
ANAB $1.5B
AnaptysBio, Inc.
NEUTRAL +8
AAVXF $12B
Abivax S.A.
NEUTRAL +2
BCHMF $6.8B
Bachem Holding AG
NEUTRAL +2
TXG $9.3B
10x Genomics, Inc.
NEUTRAL +1
ABCL $3.8B
AbCellera Biologics Inc.
NEUTRAL +1
LYCA $1.6B
Lycia Therapeutics Inc.
N/A 0
JANX $1.0B
Janux Therapeutics, Inc.
NEUTRAL -1
ODTX $940M
Odyssey Therapeutics, Inc.
NEUTRAL -2
PHMMF $1.6B
Pharma Mar, S.A.
NEUTRAL -3
ADPT $4.1B
Adaptive Biotechnologies Corporation
NEUTRAL -7
ZLAB $2.7B
Zai Lab Limited
NEUTRAL -8
ZBIO $1.8B
Zenas BioPharma, Inc.
NEUTRAL -8
RYTM $6.2B
Rhythm Pharmaceuticals, Inc.
NEUTRAL -9
GLPGF $2.1B
Lakefront Biotherapeutics
LEAN BEAR -12
EWTX $4.2B
Edgewise Therapeutics, Inc.
LEAN BEAR -16
ARGX $55B
argenx SE
LEAN BEAR -18
SRRK $5.0B
Scholar Rock Holding Corporation
LEAN BEAR -18
ACAD $3.4B
Acadia Pharmaceuticals Inc.
LEAN BEAR -18
JBIO $930M
Jade Biosciences, Inc.
LEAN BEAR -18
CGEM $880M
Cullinan Therapeutics, Inc.
LEAN BEAR -18
HNGZY $6.9B
Hangzhou Tigermed Consulting Co., Ltd
LEAN BEAR -20
SHJBF $4.8B
Shanghai Junshi Biosciences Co., Ltd.
LEAN BEAR -20
ADRX $1.9B
ADARx Pharmaceuticals, Inc.
LEAN BEAR -20
MIRM $5.2B
Mirum Pharmaceuticals, Inc.
LEAN BEAR -22
CELC $3.2B
Celcuity Inc.
LEAN BEAR -22
INCY $23B
Incyte Corporation
LEAN BEAR -23
TWST $9.2B
Twist Bioscience Corporation
LEAN BEAR -24
INBX $1.4B
Inhibrx Biosciences Inc.
LEAN BEAR -24
KARD $1.1B
Kardigan, Inc.
LEAN BEAR -24
NURPF $1.8B
Neuren Pharmaceuticals Limited
LEAN BEAR -26
IMNM $2.1B
Immunome, Inc.
LEAN BEAR -27
XENE $3.4B
Xenon Pharmaceuticals Inc.
BEARISH -31
TSHA $1.3B
Taysha Gene Therapies, Inc.
BEARISH -31
SNBIF $1.3B
SanBio Company Limited
BEARISH -33
TNGX $3.9B
Tango Therapeutics, Inc.
BEARISH -34
TRVI $1.8B
Trevi Therapeutics, Inc.
BEARISH -34
QURE $1.6B
uniQure N.V.
BEARISH -34
BPMUF $960M
Basilea Pharmaceutica AG
BEARISH -34
WXIBF $26B
WuXi Biologics (Cayman) Inc.
BEARISH -35
RAPP $1.2B
Rapport Therapeutics, Inc. Common Stock
BEARISH -35
MEOBF $2.0B
Mesoblast Limited
BEARISH -37
PRAX $7.1B
Praxis Precision Medicines, Inc.
BEARISH -40
CLDX $2.3B
Celldex Therapeutics, Inc.
BEARISH -40
BCRX $1.9B
BioCryst Pharmaceuticals, Inc.
BEARISH -40
APMD $790M
Apnimed, Inc.
BEARISH -40
PPTDF $870M
PeptiDream Inc.
BEARISH -41
CSPHF $1.4B
CStone Pharmaceuticals
BEARISH -42
DRTSW $1.2B
Alpha Tau Medical Ltd.
BEARISH -42
PCVX $9.5B
Vaxcyte, Inc.
BEARISH -47
IDRSF $1.4B
Idorsia Ltd
BEARISH -47
DNLI $2.9B
Denali Therapeutics Inc.
BEARISH -48
CRVS $890M
Corvus Pharmaceuticals, Inc.
BEARISH -48
SVRA $870M
Savara Inc.
BEARISH -48
ARWR $8.2B
Arrowhead Pharmaceuticals, Inc.
BEARISH -49
IONS $7.1B
Ionis Pharmaceuticals, Inc.
BEARISH -49
PTCT $5.1B
PTC Therapeutics, Inc.
BEARISH -49
AMLX $3.4B
Amylyx Pharmaceuticals, Inc.
BEARISH -49
MBX $2.3B
MBX Biosciences, Inc. Common Stock
BEARISH -49
IMTX $1.1B
Immatics N.V.
BEARISH -49
KURA $850M
Kura Oncology, Inc.
BEARISH -49
DNTH $4.3B
Dianthus Therapeutics, Inc.
BEARISH -52
GHRS $1.2B
GH Research PLC
BEARISH -52
ABUS $830M
Arbutus Biopharma Corp
BEARISH -52
GNNSF $9.6B
Genscript Biotech Corporation
BEARISH -53
CGON $5.5B
CG Oncology Inc.
BEARISH -58
CRSP $4.8B
CRISPR Therapeutics AG
BEARISH -58
PBLS $3.0B
Parabilis Medicines, Inc.
BEARISH -58
MLYS $1.8B
Mineralys Therapeutics, Inc.
BEARISH -58
GENB $1.6B
Generate Biomedicines, Inc.
BEARISH -58
CMPS $1.6B
COMPASS Pathways plc
BEARISH -58
NKTR $1.1B
Nektar Therapeutics
BEARISH -58
AVBP $1.0B
ArriVent BioPharma, Inc.
BEARISH -58
ALMS $880M
Alumis Inc.
BEARISH -58
SANA $700M
Sana Biotechnology, Inc.
BEARISH -58
IVBXF $20B
Innovent Biologics, Inc.
BEARISH -59
CAMRF $3.7B
Camurus AB
BEARISH -59
ORIC $1.4B
ORIC Pharmaceuticals, Inc.
BEARISH -59
IMVT $5.9B
Immunovant, Inc.
BEARISH -60
HRMY $2.1B
Harmony Biosciences Holdings, Inc.
BEARISH -60
ANRO $860M
Alto Neuroscience, Inc.
BEARISH -60
RCUS $2.3B
Arcus Biosciences, Inc.
BEARISH -62
AVLN $1.1B
Avalyn Pharma Inc. Common Stock
BEARISH -65
BCAX $1.1B
Bicara Therapeutics Inc. Common Stock
BEARISH -65
MNKD $1.0B
MannKind Corporation
BEARISH -65
GLUE $920M
Monte Rosa Therapeutics, Inc.
BEARISH -65
RVMDW $40B
Revolution Medicines, Inc. Warrant
BEARISH -66
ALNY $30B
Alnylam Pharmaceuticals, Inc.
BEARISH -66
KRYS $9.2B
Krystal Biotech, Inc.
BEARISH -66
INVA $1.5B
Innoviva, Inc.
BEARISH -66
BMRN $11B
BioMarin Pharmaceutical Inc.
BEARISH -69
IBRX $8.7B
ImmunityBio, Inc.
BEARISH -69
DRTS $1.2B
Alpha Tau Medical Ltd
BEARISH -69
TARS $3.2B
Tarsus Pharmaceuticals, Inc.
BEARISH -75
AAPG $1.4B
Ascentage Pharma Group International
BEARISH -75
OMER $1.2B
Omeros Corporation
BEARISH -75
ASCLF $770M
Ascletis Pharma Inc.
BEARISH -75
BLTE $5.9B
Belite Bio, Inc
BEARISH -78
NUVB $1.6B
Nuvation Bio Inc.
BEARISH -78
NVAX $1.6B
Novavax, Inc.
BEARISH -78
MGTX $880M
MeiraGTx Holdings plc
BEARISH -78
CYTK $8.5B
Cytokinetics, Incorporated
BEARISH -82
NAMS $2.3B
NewAmsterdam Pharma Company N.V.
BEARISH -82
HBMHF $1.3B
HBM Holdings Limited
BEARISH -82
GERN $720M
Geron Corporation
BEARISH -82
RVMD $40B
Revolution Medicines, Inc.
BEARISH -84
BNTX $22B
BioNTech SE
BEARISH -84
IDYA $3.4B
IDEAYA Biosciences, Inc.
BEARISH -84
TLX $3.1B
Telix Pharmaceuticals Limited
BEARISH -84
PGEN $2.2B
Precigen, Inc.
BEARISH -84
JAZZ $14B
Jazz Pharmaceuticals plc
BEARISH -87
MDGL $10B
Madrigal Pharmaceuticals, Inc.
BEARISH -87
TVTX $4.7B
Travere Therapeutics, Inc.
BEARISH -87
URGN $1.7B
UroGen Pharma Ltd.
BEARISH -87
MDCLF $1.1B
MedinCell S.A.
BEARISH -87
IMMX $680M
Immix Biopharma, Inc.
BEARISH -87
INSM $20B
Insmed Incorporated
BEARISH -91
REGMF $5.6B
RemeGen Co., Ltd.
BEARISH -91
GENSF $1.8B
Genus plc
BEARISH -91
OCUL $1.4B
Ocular Therapeutix, Inc.
BEARISH -91
GPCR $1.2B
Structure Therapeutics Inc.
BEARISH -91
SNDX $1.2B
Syndax Pharmaceuticals, Inc.
BEARISH -91
AKTS $850M
Aktis Oncology, Inc.
BEARISH -91
ARDX $770M
Ardelyx, Inc.
BEARISH -91
SMMT $12B
Summit Therapeutics Inc.
BEARISH -100
AXSM $7.6B
Axsome Therapeutics, Inc.
BEARISH -100
TRSBF $4.3B
3SBio Inc.
BEARISH -100
VKTX $3.1B
Viking Therapeutics, Inc.
BEARISH -100
BRCTF $2.6B
BioArctic AB
BEARISH -100
ZLDPF $2.4B
Zealand Pharma A/S
BEARISH -100
INCPF $2.4B
InnoCare Pharma Limited
BEARISH -100
IVEVF $750M
Inventiva S.A.
BEARISH -100

Peer Comparison

Symbol Mkt Cap P/E ROE % ROIC % Net Mgn % Rev Grw % Piotroski Signal 1Y Ret %
VERA Vera Therapeutics, Inc. $2.0B -5.1 -91.8 2030.6 — — 1 BEARISH 2.6
LZAGY Lonza Group AG $54B -412.9 13.5 10.5 17.5 -9.7 8 BULLISH 4.3
ASND Ascendis Pharma A/S $15B 18.2 121.1 76.2 61.0 114.8 7 BULLISH 21.7
HALO Halozyme Therapeutics, Inc. $14B 36.5 173.7 32.5 47.8 41.2 5 BULLISH 94.3
CAI Caris Life Sciences, Inc. $9.1B 91.5 20.1 61.1 -0.2 445.5 7 BULLISH 8.4
MANE Veradermics, Incorporated $5.8B — — — — — — BULLISH —
BVNRY Bavarian Nordic A/S $2.9B 13.0 12.3 7.1 36.0 -5.8 7 BULLISH 1.9
NRIX Nurix Therapeutics, Inc. $2.8B 10.6 44.0 -1896.6 81.7 738.8 8 BULLISH 140.8
FTRE Fortrea Holdings Inc. $2.2B -26.2 -15.3 0.6 -1.9 -2.1 6 BULLISH 116.2
AGIO Agios Pharmaceuticals, Inc. $2.2B -5.4 -34.3 -82.5 -225.1 140.6 4 BULLISH -12.2
LKFT Lakefront Biotherapeutics N.V. $2.1B — — — — — — BULLISH —
SEPN Septerna Inc $1.9B -81.5 -6.3 -93.1 -48.7 17878.5 5 BULLISH 103.7
COAG Hemab Therapeutics Holdings, Inc. Common Stock $1.6B — — — — — — BULLISH —
VSTM Verastem, Inc. $910M -4.1 -471.2 6197.3 -86.5 3995.7 4 BULLISH 27.0
SOLTF Nxera Pharma Co., Ltd. $770M -15.8 -12.0 -1.7 -2.6 7.5 4 BULLISH 38.2
REGN Regeneron Pharmaceuticals, Inc. $83B 19.4 14.0 12.9 30.2 9.3 7 BULLISH 41.4
EXEL Exelixis, Inc. $16B 19.8 44.4 69.0 33.7 9.2 8 BULLISH 68.8
ARQT Arcutis Biotherapeutics, Inc. $3.9B 143.7 15.9 34.7 11.6 76.1 7 BULLISH 57.5
VCEL Vericel Corporation $2.2B 90.6 7.2 5.9 2.8 23.0 7 BULLISH 19.1
MRVI Maravai LifeSciences Holdings, Inc. $2.1B -15.3 -32.9 24.4 -24.1 -3.3 5 BULLISH 142.2
KLRA Kailera Therapeutics, Inc. $1.7B — — — — — — BULLISH —
SPTX Seaport Therapeutics, Inc. Common Stock $1.1B — — — — — — BULLISH —
SGP SpyGlass Pharma, Inc. Common Stock $950M — — — — — — BULLISH —
VRDN Viridian Therapeutics, Inc. $2.5B -6.7 -65.7 418.2 -44760.2 23220.3 4 BULLISH 8.7
ADMA ADMA Biologics, Inc. $2.4B 15.4 41.9 35.5 30.4 8.0 5 BULLISH -26.4
UTHR United Therapeutics Corporation $25B 19.5 19.3 31.3 42.5 2.5 6 BULLISH 41.2
KYMR Kymera Therapeutics, Inc. $9.1B -36.7 -24.2 -30.7 -94.2 134.8 6 BULLISH 100.8
LEGN Legend Biotech Corporation $3.6B -42.9 -8.1 -8.2 8.6 59.5 4 BULLISH -32.3
VIR Vir Biotechnology, Inc. $1.8B -6.2 -26.1 -38.8 33.5 1495.9 5 BULLISH 93.5
MAZE Maze Therapeutics, Inc. $1.7B -11.4 -37.3 -112.3 — — 3 BULLISH 4.3
GNMSF Genmab A/S $28B 34.9 3.9 11.9 26.2 -82.1 4 BULLISH 47.7
SYRE Spyre Therapeutics, Inc. $8.3B -50.4 -23.0 359.8 — — 3 BULLISH 323.8
TGTX TG Therapeutics, Inc. $8.3B 18.5 100.3 73.5 3.2 76.1 6 BULLISH 69.3
ORKA Oruka Therapeutics, Inc. $5.3B -38.6 -18.2 -50.3 — — 4 BULLISH 251.6
IRON Disc Medicine, Inc. $2.9B -12.1 -39.1 1672.3 — — 1 BULLISH -6.7
BHVN Biohaven Ltd. $2.1B -3.3 -799.5 -1083.0 — — 3 BULLISH -7.9
ZYME Zymeworks Inc. $2.0B -14.3 -72.3 -156.9 -980.8 -69.8 2 BULLISH 62.6
LBRX LB Pharmaceuticals Inc Common Stock $1.2B -13.4 -25.8 -768.9 — — 2 BULLISH 148.2
OABIW OmniAb, Inc. $1.1B -13.8 -16.9 -16.8 -43.7 66.9 6 BULLISH -17.6
RIGL Rigel Pharmaceuticals, Inc. $900M 2.8 126.9 88.5 22.0 3.3 4 BULLISH 68.7
ONTTF Oxford Nanopore Technologies plc $2.7B -18.0 -25.6 -36.2 -41.1 14.4 4 BULLISH 41.7
NBIX Neurocrine Biosciences, Inc. $15B 20.6 22.1 16.0 15.1 34.4 6 BULLISH 1.4
ERAS Erasca, Inc. $5.0B -15.8 -78.2 -87.5 — — 2 BULLISH 539.5
RARE Ultragenyx Pharmaceutical Inc. $1.5B -2.9 839.4 -67.5 -43.0 17.5 2 BULLISH -50.0
CSLLY CSL Limited $134B -26.1 -15.2 13.1 -40.2 1.7 4 BULLISH 1.4
LGND Ligand Pharmaceuticals Incorporated $6.0B 31.2 22.0 11.3 76.2 54.9 5 BULLISH 66.7
AUPH Aurinia Pharmaceuticals Inc. $2.2B 7.3 66.1 127.2 45.0 19.8 7 BULLISH 45.1
XNCR Xencor, Inc. $1.9B -13.7 -29.1 -152.4 -42.4 -36.1 2 BULLISH 127.0
TRAX First Tracks Biotherapeutics Inc $1.6B — — — — — — BULLISH —
SLN Silence Therapeutics plc $930M -5.2 -90.4 157.8 — -97.6 1 BULLISH 171.0
NBTX Nanobiotix S.A. $1.5B -27.5 104.2 62.0 -626.0 49.1 4 BULLISH 79.8
SLS SELLAS Life Sciences Group, Inc. $2.3B -57.2 -39.6 55646.0 — — 4 BULLISH 511.6
NTLA Intellia Therapeutics, Inc. $1.6B -3.6 -55.4 -92.1 -1392.3 12.6 5 BULLISH -52.0
PHAR Pharming Group N.V. $710M 81.8 3.6 3.2 1.8 7.8 7 BULLISH -12.7
TECH Bio-Techne Corporation $11B 62.1 9.0 8.9 17.0 -0.4 7 BULLISH 10.3
IOVA Iovance Biotherapeutics, Inc. $6.4B -20.1 -40.4 -49.1 -47.6 34.5 6 BULLISH 548.0
KOD Kodiak Sciences Inc. $5.5B -21.7 -368.4 -630.1 — — 1 BULLISH 388.6
MRNA Moderna, Inc. $80B -25.8 -39.0 -90.1 -539.3 -27.2 2 BULLISH 724.0
AKBLF ALK-Abelló A/S $7.4B 39.9 21.2 23.9 18.9 16.4 8 BULLISH 12.8
CASBF CanSino Biologics Inc. $1.4B 367.7 0.8 -1.2 11.0 32.5 7 BULLISH -25.5
REPL Replimune Group, Inc. $1.1B -4.2 -134.3 -1055.2 — — 1 BULLISH 48.3
ROIV Roivant Sciences Ltd. $26B -95.9 -6.2 -217.5 -13164.4 -67.6 1 BULLISH 100.5
ABSI Absci Corporation $1.6B -13.4 -57.7 -213.1 -10443.4 -62.3 5 BULLISH 147.5
XERS Xeris Biopharma Holdings, Inc. $1.9B -107.0 118.2 18.3 -33.8 36.3 6 BULLISH 13.5
BBIO BridgeBio Pharma, Inc. $13B -19.3 32.4 57.9 -62.5 202.4 4 BULLISH 27.9
VOR Vor Biopharma Inc. $990M 0.1 -73.6 22.2 — — 3 BULLISH -28.1
ONC BeOne Medicines AG $40B 25.2 14.7 57.2 13.9 34.3 8 BULLISH 17.9
RXRX Recursion Pharmaceuticals, Inc. $2.0B -3.9 -56.6 -99.7 -1708.0 -14.9 4 BULLISH -33.0
IMCR Immunocore Holdings plc $1.6B -176.2 -2.3 -472.0 -0.7 13.4 4 BULLISH -3.4
DMRA Damora Therapeutics, Inc. $1.3B — — — — — — BULLISH —
MLTX MoonLake Immunotherapeutics $1.0B -3.1 -67.4 2902.7 — — 1 BULLISH 25.3
COGT Cogent Biosciences, Inc. $5.4B -13.9 -109.7 1964.0 — — 3 BULLISH 111.6
ALMR Alamar Biosciences, Inc. $2.1B — — — — — — BULLISH —
VRTX Vertex Pharmaceuticals Incorporated $133B 29.9 23.5 28.3 33.0 10.6 6 BULLISH 23.6
RLAY Relay Therapeutics, Inc. $4.0B -12.0 -36.8 -2519.7 -23916.3 23.9 4 BULLISH 174.6
DYN Dyne Therapeutics, Inc. $2.9B -5.1 -81.6 240.4 — — 2 BULLISH -1.1
UCBJY UCB S.A. $58B 23.3 20.7 16.4 26.0 25.3 6 LEAN BULL 5.8
PTGX Protagonist Therapeutics, Inc. $9.0B 115.5 11.0 84.1 76.3 34.8 7 LEAN BULL 88.5
DFTX Definium Therapeutics, Inc. $4.8B -10.8 -25.7 82.4 — — 2 LEAN BULL —
ELVN Enliven Therapeutics, Inc. $3.0B -26.5 -15.3 -6535.0 — — 3 LEAN BULL 112.0
PHVS Pharvaris N.V. $2.2B -10.6 -70.7 860.9 — — 4 LEAN BULL 39.0
STOK Stoke Therapeutics, Inc. $1.6B -7.8 -61.1 -318.5 -660.8 -86.2 2 LEAN BULL -19.1
BRVE Braveheart Bio, Inc. $1.5B — — — — — — LEAN BULL —
PVLA Palvella Therapeutics, Inc. $1.8B -27.4 -46.6 137.5 — — 3 LEAN BULL 82.1
TYRA Tyra Biosciences, Inc. $1.2B -8.9 -45.3 -2390.9 — — 2 LEAN BULL 51.2
BEAM Beam Therapeutics Inc. $2.5B -30.2 -8.1 -184.5 -25036.3 158.9 4 LEAN BULL -10.9
SRPT Sarepta Therapeutics, Inc. $1.9B -13.0 -9.5 -6.3 -1.2 -20.4 4 NEUTRAL -17.2
ANAB AnaptysBio, Inc. $1.5B 7.3 -1146.3 466.0 668.9 92.9 5 NEUTRAL 112.3
AAVXF Abivax S.A. $12B -17.0 -221.8 440.6 — -133.5 4 NEUTRAL 57.0
BCHMF Bachem Holding AG $6.8B 41.9 10.6 8.2 15.4 4.3 3 NEUTRAL 24.7
TXG 10x Genomics, Inc. $9.3B -132.5 -9.4 -19.8 -11.9 -4.3 5 NEUTRAL 466.6
ABCL AbCellera Biologics Inc. $3.8B -23.5 -17.3 -36.2 -1368.6 101.3 4 NEUTRAL 126.7
LYCA Lycia Therapeutics Inc. $1.6B — — — — — — N/A —
JANX Janux Therapeutics, Inc. $1.0B -10.4 -10.7 516.9 -214.0 7162.0 4 NEUTRAL -30.7
ODTX Odyssey Therapeutics, Inc. $940M — — — — — — NEUTRAL —
PHMMF Pharma Mar, S.A. $1.6B 21.2 24.9 35.9 -2.0 15.5 7 NEUTRAL 1.7
ADPT Adaptive Biotechnologies Corporation $4.1B -68.5 -39.6 -14.1 -55.6 50.1 5 NEUTRAL 60.6
ZLAB Zai Lab Limited $2.7B -13.3 -26.9 -85.4 -47.8 5.1 3 NEUTRAL -10.4
ZBIO Zenas BioPharma, Inc. $1.8B -2.9 -199.0 5842.1 -11145.6 -93.3 2 NEUTRAL 14.2
RYTM Rhythm Pharmaceuticals, Inc. $6.2B -29.5 -200.0 144.2 -69.2 53.5 4 NEUTRAL -16.6
GLPGF Lakefront Biotherapeutics $2.1B 3.8 20.2 39.4 17.4 259.3 5 LEAN BEAR -4.5
EWTX Edgewise Therapeutics, Inc. $4.2B -21.4 -38.0 1912.5 — — 1 LEAN BEAR 160.4
ARGX argenx SE $55B 41.0 26.0 50.1 29.8 162.5 7 LEAN BEAR 8.0
SRRK Scholar Rock Holding Corporation $5.0B -12.8 -167.8 931.3 — — 2 LEAN BEAR 43.2
ACAD Acadia Pharmaceuticals Inc. $3.4B 9.0 35.7 63.9 10.2 11.8 5 LEAN BEAR -8.4
JBIO Jade Biosciences, Inc. $930M -5.4 -47.8 629.9 — — 3 LEAN BEAR 47.4
CGEM Cullinan Therapeutics, Inc. $880M -4.4 -50.3 1635.6 — — 1 LEAN BEAR 91.2
HNGZY Hangzhou Tigermed Consulting Co., Ltd $6.9B 597.8 0.5 1.6 -24.2 12.0 6 LEAN BEAR 11.2
SHJBF Shanghai Junshi Biosciences Co., Ltd. $4.8B -69.3 -7.1 -6.3 4.4 29.7 5 LEAN BEAR -20.8
ADRX ADARx Pharmaceuticals, Inc. $1.9B — — — — — — LEAN BEAR —
MIRM Mirum Pharmaceuticals, Inc. $5.2B -5.9 -703.0 -27.3 -38.1 44.0 3 LEAN BEAR 22.2
CELC Celcuity Inc. $3.2B -16.0 -1433.7 1325.2 — — 3 LEAN BEAR -4.1
INCY Incyte Corporation $23B 14.3 30.7 82.1 35.0 26.9 8 LEAN BEAR 27.7
TWST Twist Bioscience Corporation $9.2B -71.7 -29.6 -29.2 -29.6 19.2 2 LEAN BEAR 368.6
INBX Inhibrx Biosciences Inc. $1.4B -11.2 -1773.6 55.8 — -100.0 4 LEAN BEAR 67.0
KARD Kardigan, Inc. $1.1B — — — — — — LEAN BEAR —
NURPF Neuren Pharmaceuticals Limited $1.8B 118.1 6.2 22.4 14.6 -68.5 5 LEAN BEAR 20.8
IMNM Immunome, Inc. $2.1B -7.4 -64.0 -2208.4 — -100.0 4 LEAN BEAR 19.6
XENE Xenon Pharmaceuticals Inc. $3.4B -7.6 -43.6 -109.7 — -100.0 3 BEARISH -11.7
TSHA Taysha Gene Therapies, Inc. $1.3B -10.1 -47.1 961.0 — -32.3 3 BEARISH -10.5
SNBIF SanBio Company Limited $1.3B -19.5 -55.8 -2935.2 — — 3 BEARISH 0.0
TNGX Tango Therapeutics, Inc. $3.9B -27.3 -21.3 -253.2 — 121.5 3 BEARISH 205.2
TRVI Trevi Therapeutics, Inc. $1.8B -39.6 -19.7 -1451.7 — — 3 BEARISH 27.0
QURE uniQure N.V. $1.6B -5.9 -157.6 37.9 -1387.8 30.2 4 BEARISH -60.2
BPMUF Basilea Pharmaceutica AG $960M 16.9 39.5 75.9 23.5 4.5 7 BEARISH 27.1
WXIBF WuXi Biologics (Cayman) Inc. $26B 31.4 10.6 16.0 20.7 16.0 9 BEARISH 20.2
RAPP Rapport Therapeutics, Inc. Common Stock $1.2B -9.1 -40.0 3981.5 — — 4 BEARISH 6.2
MEOBF Mesoblast Limited $2.0B -29.4 -9.9 -14.4 -23.4 613.8 5 BEARISH -20.0
PRAX Praxis Precision Medicines, Inc. $7.1B -20.8 -38.9 -51.2 — -100.0 4 BEARISH 53.8
CLDX Celldex Therapeutics, Inc. $2.3B -6.9 -43.9 -13685.9 -334104.5 -98.1 1 BEARISH 12.8
BCRX BioCryst Pharmaceuticals, Inc. $1.9B -5.6 87.8 62.3 35.9 68.7 5 BEARISH 12.5
APMD Apnimed, Inc. $790M — — — — — — BEARISH —
PPTDF PeptiDream Inc. $870M -38.0 -7.1 -9.6 -25.7 47.8 4 BEARISH -38.7
CSPHF CStone Pharmaceuticals $1.4B -14.4 -51.4 -340.2 -123.0 135.6 5 BEARISH -15.4
DRTSW Alpha Tau Medical Ltd. $1.2B -13.0 -141.7 -17.1 — — 3 BEARISH 807.7
PCVX Vaxcyte, Inc. $9.5B -8.0 -36.5 -66.4 — — 0 BEARISH 43.7
IDRSF Idorsia Ltd $1.4B -3.5 27.1 -344.5 -203.1 -8.1 1 BEARISH 19.6
DNLI Denali Therapeutics Inc. $2.9B -6.7 -54.9 -281.7 -3539.2 — 3 BEARISH 20.4
CRVS Corvus Pharmaceuticals, Inc. $890M -16.5 -35.4 -415.6 — — 4 BEARISH 43.4
SVRA Savara Inc. $870M -8.4 -105.5 -15438.9 — — 2 BEARISH 11.5
ARWR Arrowhead Pharmaceuticals, Inc. $8.2B -26.6 -64.8 65.7 -258.2 12.2 4 BEARISH 55.3
IONS Ionis Pharmaceuticals, Inc. $7.1B -12.7 -105.4 -58.5 -42.8 -7.4 3 BEARISH -38.0
PTCT PTC Therapeutics, Inc. $5.1B -126.1 20.6 -5.4 23.2 -42.8 2 BEARISH -6.5
AMLX Amylyx Pharmaceuticals, Inc. $3.4B -19.9 -74.7 2020.5 — 100.0 5 BEARISH 99.7
MBX MBX Biosciences, Inc. Common Stock $2.3B -22.1 -33.2 1634.0 — — 2 BEARISH 211.6
IMTX Immatics N.V. $1.1B -4.1 -47.8 -858.3 -683.4 -68.0 2 BEARISH -28.7
KURA Kura Oncology, Inc. $850M -2.9 -167.7 56.3 -327.3 -7.3 1 BEARISH 2.1
DNTH Dianthus Therapeutics, Inc. $4.3B -610.5 -4.1 -60.1 -6598.6 -60.8 3 BEARISH 141.6
GHRS GH Research PLC $1.2B -20.0 -18.8 2015.5 — — 2 BEARISH 43.5
ABUS Arbutus Biopharma Corp $830M 5.4 89.6 86.7 -507.2 1078.8 4 BEARISH -1.6
GNNSF Genscript Biotech Corporation $9.6B -14.1 -15.4 2.9 -32.0 53.1 4 BEARISH 97.7
CGON CG Oncology Inc. $5.5B -23.5 -26.4 -2066.1 -6832.8 1030.3 3 BEARISH 44.1
CRSP CRISPR Therapeutics AG $4.8B -10.7 -26.1 -253.2 -895.3 -62.7 3 BEARISH -23.9
PBLS Parabilis Medicines, Inc. $3.0B — — — — — — BEARISH —
MLYS Mineralys Therapeutics, Inc. $1.8B -4.9 -80.9 2274.6 — — 2 BEARISH -47.0
GENB Generate Biomedicines, Inc. $1.6B -7.9 -28.2 -175.0 -1065.2 — 1 BEARISH —
CMPS COMPASS Pathways plc $1.6B -2.1 -319.1 48.8 — — 2 BEARISH 88.1
NKTR Nektar Therapeutics $1.1B -5.7 -35.8 -29.2 -401.0 -27.2 3 BEARISH -36.8
AVBP ArriVent BioPharma, Inc. $1.0B -4.1 -53.1 2345.1 — — 3 BEARISH -17.2
ALMS Alumis Inc. $880M -1.8 -93.6 2645.2 -8557.2 -63.1 2 BEARISH 47.2
SANA Sana Biotechnology, Inc. $700M -3.2 -152.9 -242.3 — — 3 BEARISH -55.8
IVBXF Innovent Biologics, Inc. $20B 96.9 6.9 67.2 14.5 35.4 6 BEARISH -11.4
CAMRF Camurus AB $3.7B 58.2 15.8 89.3 34.3 -0.2 6 BEARISH -10.3
ORIC ORIC Pharmaceuticals, Inc. $1.4B -6.7 -39.8 -102.9 — — 3 BEARISH -31.3
IMVT Immunovant, Inc. $5.9B -10.2 -80.1 707.5 -2159.6 — 2 BEARISH 52.5
HRMY Harmony Biosciences Holdings, Inc. $2.1B 12.0 20.5 35.7 28.9 24.3 5 BEARISH 25.4
ANRO Alto Neuroscience, Inc. $860M -9.3 -49.2 -201.4 — — 3 BEARISH 110.7
RCUS Arcus Biosciences, Inc. $2.3B -4.6 -89.2 309.6 -222.0 -55.3 0 BEARISH 4.8
AVLN Avalyn Pharma Inc. Common Stock $1.1B — — — — — — BEARISH —
BCAX Bicara Therapeutics Inc. Common Stock $1.1B -5.6 -41.0 583.9 — — 2 BEARISH 2.0
MNKD MannKind Corporation $1.0B -23.4 71.4 4.0 -17.4 30.5 2 BEARISH -38.0
GLUE Monte Rosa Therapeutics, Inc. $920M -4.8 -42.7 149.9 -483.9 -83.9 3 BEARISH -4.3
RVMDW Revolution Medicines, Inc. Warrant $40B -21.0 -79.1 186.4 — — 1 BEARISH 2251.5
ALNY Alnylam Pharmaceuticals, Inc. $30B 37.2 100.7 -152.8 12.7 95.1 6 BEARISH -51.1
KRYS Krystal Biotech, Inc. $9.2B 38.6 20.1 40.4 45.9 22.6 7 BEARISH 72.2
INVA Innoviva, Inc. $1.5B 4.3 36.7 15.0 -69.8 19.8 7 BEARISH 18.2
BMRN BioMarin Pharmaceutical Inc. $11B 146.2 1.2 1.4 4.5 11.2 4 BEARISH 1.6
IBRX ImmunityBio, Inc. $8.7B -8.8 122.7 33.7 -449.6 192.9 4 BEARISH 249.4
DRTS Alpha Tau Medical Ltd $1.2B -13.0 -141.7 -17.1 — — 3 BEARISH 219.4
TARS Tarsus Pharmaceuticals, Inc. $3.2B -65.1 -13.7 268.1 -10.7 105.2 5 BEARISH 7.1
AAPG Ascentage Pharma Group International $1.4B -6.1 -236.8 -144.8 -270.2 170.9 3 BEARISH -58.7
OMER Omeros Corporation $1.2B 9.1 -89.2 71.8 46.4 — 5 BEARISH 131.7
ASCLF Ascletis Pharma Inc. $770M -7.8 -28.4 -7144.0 — -60.6 2 BEARISH -40.0
BLTE Belite Bio, Inc $5.9B -52.9 -20.8 -11.5 — — 3 BEARISH 57.0
NUVB Nuvation Bio Inc. $1.6B -10.3 -47.8 70.2 -198.3 1083.6 4 BEARISH -6.2
NVAX Novavax, Inc. $1.6B -6.6 323.7 29.2 -94.2 -61.6 2 BEARISH 17.6
MGTX MeiraGTx Holdings plc $880M 12.3 72.3 96.7 50.0 948.3 7 BEARISH 7.8
CYTK Cytokinetics, Incorporated $8.5B -8.5 329.8 811.2 -622.8 -17.2 2 BEARISH 6.4
NAMS NewAmsterdam Pharma Company N.V. $2.3B -9.4 -36.8 8216.2 -1732.9 -88.9 2 BEARISH -42.6
HBMHF HBM Holdings Limited $1.3B 12.5 24.1 53.0 53.0 54.6 4 BEARISH -38.1
GERN Geron Corporation $720M -11.5 -29.2 -74.1 -29.0 24.4 2 BEARISH -7.3
RVMD Revolution Medicines, Inc. $40B -21.0 -79.1 186.4 — — 1 BEARISH 241.8
BNTX BioNTech SE $22B -11.5 -9.3 -18.0 -777.3 -8.2 2 BEARISH -17.6
IDYA IDEAYA Biosciences, Inc. $3.4B -17.4 -16.2 -42.9 -1269.6 3244.7 4 BEARISH 14.8
TLX Telix Pharmaceuticals Limited $3.1B 92.5 8.6 -1.0 8.0 10.5 4 BEARISH -16.5
PGEN Precigen, Inc. $2.2B -5.4 -4640.4 -30.1 36.5 1875.0 5 BEARISH 42.0
JAZZ Jazz Pharmaceuticals plc $14B 13.6 22.1 26.4 16.0 12.6 8 BEARISH 49.3
MDGL Madrigal Pharmaceuticals, Inc. $10B -34.1 -53.3 -778.9 -15.9 149.0 2 BEARISH 4.5
TVTX Travere Therapeutics, Inc. $4.7B -112.6 -151.8 -21.0 -20.5 77.1 6 BEARISH 81.3
URGN UroGen Pharma Ltd. $1.7B -17.2 86.5 119.0 -19.8 169.5 2 BEARISH 78.8
MDCLF MedinCell S.A. $1.1B -29.2 472.2 81.6 -152.1 -14.8 3 BEARISH 333.5
IMMX Immix Biopharma, Inc. $680M -9.3 -34.2 1509.2 — — 4 BEARISH 123.0
INSM Insmed Incorporated $20B -23.0 -87.2 -364.8 -3.1 185.8 5 BEARISH -40.5
REGMF RemeGen Co., Ltd. $5.6B 9.1 108.3 139.6 83.4 283.6 7 BEARISH -7.7
GENSF Genus plc $1.8B 5.4 45.4 9.0 80.4 -3.8 5 BEARISH -19.4
OCUL Ocular Therapeutix, Inc. $1.4B -4.7 -73.0 -31671.3 -584.5 -8.1 3 BEARISH -41.5
GPCR Structure Therapeutics Inc. $1.2B -7.1 -20.2 -1134.3 — — 3 BEARISH -18.3
SNDX Syndax Pharmaceuticals, Inc. $1.2B -5.4 -255.9 -270.9 -67.8 222.3 4 BEARISH 1.2
AKTS Aktis Oncology, Inc. $850M -15.8 -29.9 276.4 -713.5 -36.1 5 BEARISH 373763.6
ARDX Ardelyx, Inc. $770M -13.2 -38.6 -22.7 -13.8 16.8 4 BEARISH -40.5
SMMT Summit Therapeutics Inc. $12B -13.7 -192.5 1714.4 — — 3 BEARISH -20.5
AXSM Axsome Therapeutics, Inc. $7.6B -37.9 -245.1 859.1 -23.5 56.9 5 BEARISH 9.8
TRSBF 3SBio Inc. $4.3B 3.4 37.1 80.3 25.3 93.8 7 BEARISH -51.7
VKTX Viking Therapeutics, Inc. $3.1B -5.3 -88.9 495.6 — — 1 BEARISH -27.7
BRCTF BioArctic AB $2.6B 263.7 5.2 77.4 -4.5 -46.1 3 BEARISH -8.6
ZLDPF Zealand Pharma A/S $2.4B 5.8 16.3 57.2 87.2 -49.2 3 BEARISH -54.1
INCPF InnoCare Pharma Limited $2.4B 18.7 12.6 45.8 23.1 108.5 4 BEARISH -50.9
IVEVF Inventiva S.A. $750M -6.2 -988.4 -371.6 -347346.6 -99.7 3 BEARISH -22.8

Profile Radar

Valuation vs Profitability

Performance Comparison

Industry Market Share

VERA vs Benchmarks

ROIC
VERA
2030.6
Industry
10.0
P/E Ratio
VERA
-5.1
Sector
27.1
ROE
VERA
-91.8
Sector
-15.1
Piotroski F
VERA
1.0
Sector
5.0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms